small molecules

Various shades of blue sewing thread spools
Biotech

Amgen weaves in UK biotech with up to $840M acquisition

Amgen has stitched together a deal worth up to $840 million for Dark Blue Therapeutics, a private biotech in Oxford.
Gabrielle Masson Jan 6, 2026 10:35am
person throwing away garbage or recycling

After $4.8B Amicus buy, BioMarin drops genetic disease asset

Dec 22, 2025 11:12am
sailing boat water yacht ocean wind

Voyager sets sail on neuro research trek with Transition Bio

Nov 10, 2025 5:23pm
hurdles

BridgeBio aces phase 3 rare disease test, clearing path to FDA

Oct 27, 2025 7:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Praxis plots path to FDA after phase 3 wins in essential tremor

Oct 16, 2025 11:48am
Graphic image of an arrow nailing the bullseye of a target

Lilly pads oral GLP-1 case with pair of phase 3 diabetes wins

Oct 15, 2025 9:48am